Shots:

• BenevolentAI will utilize its ML and data science models to identify new genes responsible for the development and progression of CCM- for which brain surgery is the only treatment option for the patients
• The collaboration is supported by the Angioma Alliance charity and funded by the Be Brave for Life Foundation and will have the direct impact on CCM pathogenesis with the potential to reduce the lifelong risk of stroke in CCM patients
• The agreement integrates bioinformatics- AI-based technology- and experimental models to inform aspects of human cardiovascular cell-biology and disease directly

Click here ­to­ read full press release/ article | Ref: BenevolentAI | Image: HBS Digital Initiative